ABECMA 260-500 x 10e6 CELULAS DISPERSION PARA PERFUSION

Bristol-Myers Squibb Pharma Eeig🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 7fff5e36cfd65077
Drug Cima Aemps Name: ABECMA 260-500 x 10e6 CELULAS DISPERSION PARA PERFUSION
Register Number: 1211539001
Holder Company Name: Bristol-Myers Squibb Pharma Eeig
Marketing Company Name: Bristol Myers Squibb S.A.
Holder Company Detail Path: /organization/bristol-myers-squibb-pharma-eeig
Authorization Date: 2022-01-20
Dosage Form: DISPERSION PARA PERFUSION
Dose: 260 - 500 × 10e6 células
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Bristol-Myers Squibb Pharma Eeig
Company Detail Path: /organization/bristol-myers-squibb-pharma-eeig

IDECABTAGEN VICLEUCEL

260–500 × 10e6 CELULAS

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Jan 20, 2022

Approval ID

7fff5e36cfd65077

Type

Standard